Clinical Trial

The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency

Study acronym: IRONDOSE
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will address whether intravenous (IV) iron repletion with a more intensive target will provide greater benefits in improving exercise capacity for patients with chronic heart failure and iron deficiency. One group of participants will receive a high-dose IV iron regimen with a more intensive target, and the other group will receive a low-dose IV iron regimen with a less intensive target.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-19; most recent amendment 2025-02-15.
Trial Details
NCT Number NCT06427343
Lead Sponsor China-Japan Friendship Hospital
Conditions Heart Failure, Iron Deficiency
Enrollment 114 participants
Start Date 2023-10-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-21 (estimated)
Updated on ClinicalTrials.gov 2025-02-19